EcoR1 Capital LLC 13D/13G Filings for Cartesian Therapeutics, Inc. (RNAC)

EcoR1 Capital LLC 13D and 13G filings for Cartesian Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
5:19 pm
Sale
2020-12-31 13G Cartesian Therapeutics, Inc.
RNAC
EcoR1 Capital LLC 76,628
2.100%
-153,257decrease
(-66.67%)
Filing